PROM1 and glioblastoma: Finally, when pathway linkages are explored in IPA (Figure A3), it has been noted that CD163, a prognostic biomarker associated with immune response in GBM, also connects to CD133 which represents a promising additional avenue for further research in conjunction with the mediators for which the effect of CD133 is currently not predicted [41,42].